Phase 2 trial more than 90% enrolled with enrollment continuing even in light of coronavirus pandemic SAN DIEGO, May 5, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”),… Read More
WARMINSTER, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its first quarter financial results, conference call… Read More
Vancouver, BC – April 30, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
TORONTO ON, April 6, 2020 – Self Care Catalysts (SCC), a digital health company that creates patient-centred disease tracking apps for clinical research around the world, today launched a free… Read More
OTTAWA/VANCOUVER, April 22, 2020 – The Canada Safe Food Consortium (CSFC), a team of Canadian foodservice leaders, medical experts, and technologists, has created a safety protocol and safe and in-kind… Read More
